Eyenovia, Senju Pharma collaborate to develop corneal epithelial wound healing candidate, SJP─0035 to treat chronic dry ...
Eyenovia, Inc., a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in paediatric progressive myopia, announced that it has entered into a collaboration agreement with Senju Pharmaceutical Co., Ltd. (Senju), under …